Arundic acid

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameArundic acid
Drug Alias Name阿伦酸acide arundiqueacidum arundicumProgliaArocyte +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAstrocytes modulatorsCyclooxygenase-2 inhibitorsFree radicals scavengers +[4] 
TargetsCyclooxygenase-2Free radicalsNitric oxide synthase, inducible
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseStroke +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOno Pharmaceutical Co LtdOno Pharma Usa IncMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseStroke +[5] 

Other Information

ATC CodeN/A
Related LinksKEGG